UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
基本信息
- 批准号:8148016
- 负责人:
- 金额:$ 1.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-03 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnimal ModelAreaBasic ScienceBiomedical ResearchCardiovascular DiseasesCellular biologyChronic Kidney FailureClinicalClinical InvestigatorClinical SciencesCollaborationsCongenital AbnormalityCore FacilityCystic Kidney DiseasesDevelopmentDevelopmental BiologyDiseaseFunctional disorderFundingGoalsGrantHumanHuman GeneticsInflammationInjuryInternal MedicineKidneyKidney DiseasesMedical centerMinerals/Electrolytes MetabolismMolecular GeneticsNephrologyPathogenesisPathologyPatientsPediatricsPhysiciansPhysiologyResearchResearch PersonnelScientistTechnologyTexasTrainingTransgenic OrganismsTranslatingTranslational ResearchUniversitiesbaseeffective therapyinsightinterdisciplinary approachmolecular pathologynephrogenesisprofessorprogramssquare footsymposium
项目摘要
DESCRIPTION, OVERALL (provided by applicant):
This is a new application for the establishment of a George M. O'Brien Kidney Research Core Center at the University of Texas Southwestern Medical Center at Dallas. The Director is Dr. Peter Igarashi, Professor of Internal Medicine and Pediatrics, and Chief of the Division of Nephrology. The overall goal of the Center is to promote bidirectional interactions between basic scientists and clinical researchers that will enhance our understanding of kidney development and pathophysiology and result in more effective treatments of kidney diseases and their complications. This goal will be achieved through the creation of new animal models of kidney diseases and the development of core facilities that will enable physician-scientists who are conducting basic research to more easily translate their findings to humans. Conversely, clinical investigators who are studying patients with renal diseases will identify molecular and genetic abnormalities that can then be studied to derive new insights into disease pathogenesis and treatment. To achieve these goals, the Center will support five Biomedical Research Cores, a Pilot & Feasibility Program, and an Educational Enrichment Program. The Biomedical Research Cores are: 1) Animal Models, 2) Physiology, 3) Cell Biology & Pathology, 4) Molecular Genetics, and 5) Clinical/Translational. The Cores will support ongoing, kidney- related research conducted at UT Southwestern, the North Texas region, nationally, and internationally. The research base consists of 41 externally funded investigators who are conducting basic research in the areas of kidney physiology & cell biology, injury & inflammation, developmental biology & molecular genetics, and renal cystic diseases. Clinical/translational research is conducted in the areas of acute & chronic kidney disease, kidney & cardiovascular disease, and electrolyte & mineral metabolism. The Center will be located in 15,000 sq ft of newly renovated space in the nephrology division and will utilize existing core facilities in human genetics, transgenic technologies, and molecular pathology. The Pilot & Feasibility Program will support two grants per year for investigators who are new to the field. The Educational Enrichment Program will include a research seminar, annual symposium, training grants, and courses offered by a new Dept. of Clinical Sciences. By strengthening existing collaborations and attracting outside investigators, the Center will promote new multidisciplinary approaches to understanding the causes and treatment of renal diseases.
描述,总体(由申请人提供):
这是在达拉斯西南医学中心建立乔治·奥布莱恩肾脏研究核心中心的新应用。主任是内科和儿科教授彼得·伊加拉西(Peter Igarashi)博士,肾脏病科负责人。该中心的总体目标是促进基础科学家与临床研究人员之间的双向相互作用,这将增强我们对肾脏发育和病理生理学的理解,并导致对肾脏疾病及其并发症的更有效治疗。通过创建新的肾脏疾病动物模型以及核心设施的发展,将实现这一目标,这些核心设施将使医师科学家能够进行基础研究,从而更轻松地将其发现转化为人类。相反,正在研究肾脏疾病患者的临床研究人员将鉴定分子和遗传异常,然后可以研究这些异常,以获取有关疾病发病机理和治疗的新见解。为了实现这些目标,该中心将支持五个生物医学研究核心,一个试验和可行性计划以及一个教育丰富计划。生物医学研究核心是:1)动物模型,2)生理学,3)细胞生物学和病理学,4)分子遗传学,以及5)临床/转化。这些核心将支持正在进行的肾脏相关研究,该研究在UT西南部,北德克萨斯州,国内和国际上进行。该研究基础由41位由外部资助的研究者组成,他们正在肾脏生理与细胞生物学,损伤和炎症,发育生物学和分子遗传学以及肾囊性疾病领域进行基础研究。临床/翻译研究在急性和慢性肾脏疾病,肾脏和心血管疾病以及电解质和矿物质代谢领域进行。该中心将位于肾脏科的15,000平方英尺的新装修空间中,并将利用人类遗传学,转基因技术和分子病理学中的现有核心设施。飞行员与可行性计划将为该领域新手的调查人员提供每年两项赠款。教育丰富计划将包括一项研究研讨会,年度研讨会,培训补助金以及新的临床科学系提供的课程。通过加强现有的合作并吸引外部调查人员,该中心将促进新的多学科方法来了解肾脏疾病的原因和治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Igarashi其他文献
Peter Igarashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Igarashi', 18)}}的其他基金
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7832043 - 财政年份:2009
- 资助金额:
$ 1.9万 - 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7936337 - 财政年份:2009
- 资助金额:
$ 1.9万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7883980 - 财政年份:2009
- 资助金额:
$ 1.9万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8097975 - 财政年份:2007
- 资助金额:
$ 1.9万 - 项目类别:
UT southwestern O'Brien Kidney Research Core Center
德克萨斯大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8912182 - 财政年份:2007
- 资助金额:
$ 1.9万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7325171 - 财政年份:2007
- 资助金额:
$ 1.9万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
- 批准号:
10702126 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Project 2: Informing oral nicotine pouch regulations to promote public health
项目 2:告知口服尼古丁袋法规以促进公共卫生
- 批准号:
10666068 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Consequences of Perinatal Nicotine Exposure on Functional Brainstem Development
围产期尼古丁暴露对功能性脑干发育的影响
- 批准号:
10752337 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
CSRD Research Career Scientist Award Application
CSRD研究职业科学家奖申请
- 批准号:
10701136 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别:
Changes in the Ionic Basis of GABAergic Inhibition that Contribute to Post-traumatic Epilepsy
导致创伤后癫痫的 GABA 能抑制离子基础的变化
- 批准号:
10713240 - 财政年份:2023
- 资助金额:
$ 1.9万 - 项目类别: